Trials / Unknown
UnknownNCT01270490
Efficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of Candidemia
A Multicentre, Prospective, Randomized Open-label Pilot Study to Assess the Feasibility and Preliminary Efficacy of Interferon-gamma in Combination With Anidulafungin for the Treatment of Candidemia
- Status
- Unknown
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 20 (estimated)
- Sponsor
- Radboud University Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the feasibility and preliminary efficacy of interferon-gamma in combination with anidulafungin for the treatment of candidemia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Interferon-gamma, Recombinant | Interferon 50 mcg/m2 to be administered three times per week during two weeks |
Timeline
- Start date
- 2011-01-01
- Primary completion
- 2013-01-01
- First posted
- 2011-01-05
- Last updated
- 2012-02-14
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT01270490. Inclusion in this directory is not an endorsement.